The treatment of psoriasis with triacetoxyanthracene
Whitefield, M.
Arzneimittel-Forschung 20(1): 137-139
1970
ISSN/ISBN: 0004-4172 PMID: 5467436 Document Number: 27837
Document emailed within 1 workday
Related Documents
Wong, J.W.; Kamangar, F.; Nguyen, T.V.; Koo, J.Y.M. 2012: Excimer laser therapy for hairline psoriasis: a useful addition to the scalp psoriasis treatment algorithm Skin Therapy Letter 17(5): 6-9Chowaniec, O.; Blichowska, T. 1979: Case of generalized pustular psoriasis caused by corticosteroid treatment of simple psoriasis and pemphigus Przeglad Dermatologiczny 66(5): 541-544
Au, S-Chung.; Madani, A.; Alhaddad, M.; Alkofide, M.; Gottlieb, A.B. 2013: Comparison of the efficacy of biologics versus conventional systemic therapies in the treatment of psoriasis at a comprehensive psoriasis care center Journal of drugs in dermatology: JDD 12(8): 861-866
Balevi, A.; Olmuşçelik, O.; Ustuner, P.; Özdemir, M. 2018: Is there any Correlation between Red Cell Distribution Width, Mean Platelet Volume Neutrophil Count, Lymphocyte Count, and Psoriasis Area Severity Index in Patients Under Treatment for Psoriasis? Acta Dermatovenerologica Croatica: Adc 26(3): 199-205
DiBonaventura, M.daCosta.; Wagner, S.; Waters, H.; Carter, C. 2010: Treatment patterns and perceptions of treatment attributes, satisfaction and effectiveness among patients with psoriasis Journal of Drugs in Dermatology: Jdd 9(8): 938-944
Chang, M.B.; Sri, J.C.; Driscoll, M.; Gaspari, A.A. 2011: Mycobacterium fortuitum infection following adalimumab treatment for psoriasis and subsequent complication-free treatment with alternate TNF-a blockers Journal of Drugs in Dermatology: Jdd 10(8): 914-916
Bonomo, L.; Abittan, B.J..; Hashim, P.W..; Karki, C.; Mason, M.; Lebwohl, M. 2019: Combination use of Systemic Therapies in Psoriasis: Baseline Characteristics from the Corrona Psoriasis Registry Journal of Drugs in Dermatology: Jdd 18(8): 731-740
Hellgren, L. 1976: Induction of generalized pustular psoriasis by topical use of betamethasone-dipropionate ointment in psoriasis Annals of Clinical Research 8(5): 317-319
Miemiec, E. 1970: Quantitative determination of IgM in serum of patients with psoriasis vulgaris with respect to psoriasis arthropathica Dermatologische Monatschrift 156(5): 490-492
Kwan, Z.; Yeoh, C.A.; Mohd Affandi, A.; Alias, F.A.; Hamid, M.; Baharum, N.; Yong, A.S.W.; Baba, R. 2015: Causes of mortality in patients with psoriasis in Malaysia - Evidence from the Malaysian Psoriasis Registry Medical Journal of Malaysia 70(5): 273-277
Kragballe, K. 1993: Treatment of psoriasis Nordisk Medicin 108(2): 42-47
Tapernoux, B. 1989: Ambulatory treatment of psoriasis Therapeutische Umschau. Revue Therapeutique 46(2): 123-127
Thappa, D.M.; Laxmisha, C. 2004: Immunomodulators in the treatment of psoriasis Indian Journal of Dermatology Venereology and Leprology 70(1): 1-9
Wentzell, J.M.; Baughman, R.D.; O'Connor, G.T.; Bernier, G.M. 1987: Cyclosporine in the treatment of psoriasis Archives of Dermatology 123(2): 163-165
Muller, S.A. 1984: Topical treatment of psoriasis with tar Acta Dermato-Venereologica. Supplementum 112: 7-10
Brown, M.D.; Gupta, A.K.; Ellis, C.N.; Cooper, K.D.; Fisher, G.J.; Voorhees, J.J. 1988: Cyclosporine for the treatment of psoriasis Transplantation Proceedings 20(3 Suppl 4: 26-31
Diurd', P.I. 1978: Use of heparin for treatment of psoriasis Vestnik Dermatologii i Venerologii 3: 69-70
Shelmire, D.S. 1970: Methotrexate treatment of psoriasis Texas Medicine 66(2): 88-91
Guilhou, J-Jacques. 2002: Psoriasis treatment update La Revue du Praticien 52(17): 1861-1863
Pavithran, K. 2001: Psoriasis: topical treatment Indian Journal of Dermatology Venereology and Leprology 67(2): 85